Active immunization in HIV-infected patients

Pharmacotherapy

Volumn 16, Issue 2 I, 1996, Pages 163-170

  Pau, Alice K ^a   McNicholl, Ian R ^a   Pursell, Kenneth J ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

ACTIVE IMMUNIZATION; ADULT; CHILD; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; LOBAR PNEUMONIA; REVIEW; UNITED STATES;

AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; HAEMOPHILUS VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; PNEUMOCOCCAL INFECTIONS; VACCINATION;

EID: 0029984615     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Masur H. Problems in the management of opportunistic infections in patients infected with human immunodeficiency virus. J Infect Dis 1990;161:858-64.
2. Polsky B, Gold JWM, Whimbey E, et al. Bacterial pneumonia in patients with acquired immunodeficiency syndrome. Ann Intern Med 1986;104.38-41.
3. Rustgi VK, Hoofnagle JH, Gerin JL, et al. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:795-7.
4. Wortley PM, Farizo KM. Pneumococcal and influenza vaccination levels among HIV infected adolescents and adults receiving medical care in the United States. AIDS 1994;8:941-4.
5. Rabeneck L, Risser JMH, Murray NGB, McCabe BK, Lacke CE, Lucco LJ. Failure of providers to vaccinate HIV infected men against hepatitis B: a missed opportunity. Am J Gastroenterol 1993,88(12):2015-17
6. Redfield RR, Wright DC, James WD, Jones TS, Brown, Burke DS. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 1987,316 673-6.
7. Lumb R, Shaw D. Mycobacterium bovis (BCG) vaccination - progressive disease in a patient asymptomatically infected with the human immunodeficiency virus. Med J Aust 1992;156:286-7.
8. Smith E, Thybo S, Bennedsen J. Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand J Infect Dis 1992,24:109-10.
9. Centers for Disease Control. Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immune deficiency syndrome MMWR 1985;34:227-8.
10. Margolick JB, Volkman M, Folks TM, Fauci AS. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J Immunol 1987,138:1719-23.
11. Ho DD. HIV-1 viraemia and influenza [letter]. Lancet 1992:339(8839). 1549.
12. O'Brien WA, Ovack S, Kalhor H, Mao SH, Zack JA. HIV-1 replication can be increased in blood from seropositive patients following influenza immunization. Presented at the IX International Conference on AIDS, Berlin, June 1993.
13. Huang K-L, Ruben FL, Rinaldo CR, Kingsley L, Lyter DW, Ho M. Antibody responses after influenza and pneumococcal immunization in HIV infected homosexual men JAMA 1987,257:2047-50.
14. Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 1988.109:383-8.
15. Halsey NA, Henderson DA. HIV infection and immunization against other agents. N Engl J Med 1987,316 683-5.
16. Kroon FP, van Dissel JT, deJong JC, Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994;8(4):469-76.
17. Opravil M, Fierz W, Matter L, Blaser J, Luthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infecied patients Clin Exp Immunol 1991,84:185-9
18. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B cell activation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983:309:453-8
19. Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome J Pediatr 1985;107:352-7
20. Rodriguez-Barradas MC, Musher DM, Lahart C, et al. Antibody to capsular polysaccharides of Streptococcus pneumnoniae after vaccination of human immunodeficiency virus-infected subjecls with 23-valent pneumococcal vaccine. J Infect Dis 1992;165:553-6.
21. Barbi M, Biffi MR, Binda S, et al. Immunization in children with HIV seropositivity at birth: antibody response to polio vaccine and tetanus toxoid AIDS 1992;6:1465-9.
22. Brena AE, Cooper ER, Cabral HJ, Pehon SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immun Defic Synd 1993;6(10):1125-9.
23. Immunization Practices Advisory Committee. Use of vaccines and immune globulins in persons with altered immunocompetence MMWR 1993;42(RR-4).1-18.
24. Immunization Practices Advisory Committee. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR 1986,35: 595-606
25. Immunization Practices Advisory Committee. Immunization of children infected with human immunodeficiency virus - supplementary ACIP statement MMWR 1988;37:181-2.
26. von Reyn CF, Clements CJ, Mann JM. Human immunodeficiency virus infection and routine childhood immunization. Lancet 1987;2:669-72.
27. Immunization Practices Advisory Committee. General recommendations on immunization. MMWR 1994,43(RR-1):1-38.
28. Collier AC, Corey L, Murphy V, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109: 101-5.
29. Immunization Practices Advisory Committee. Measles prevention. MMWR 1989,38(5-9):1-18.
30. Immunization Practices Advisory Committee. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. MMWR 1991;40(RR-1):1-7.
31. Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991;40(RR-13).1-25.
32. Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine MMWR 1989;38:64-76
33. Immunization Practices Advisory Committee. Prevention and control of influenza. MMWR 1994,43(RR-9):1-13.
34. McLaughlin M, Thomas P, Onorato I, et al. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. Pediatrics 1988,82.229-33
35. Onorato IM, Markowitz LE, Oxtoby MJ. Childhood immunization, vaccine-preventable diseases and HIV infection. Pediatr Infect Dis J 1988;7:588-95
36. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era JAMA 1993;269 221-6.
37. Nkowane BM, Wassilak SGF, Orenstein WA, et al. Vaccine-associated paralytic poliomyelitis JAMA 1987,257(10): 1335-40.
38. Anonymous. Measles in HIV-infected children, United States MMWR 1988,37:183-6
39. Immunization Practices Advisory Committee. Update on adult immunizations. MMWR 1991;40(RR-12):1-94.
40. Immunization Practices Advisory Committee. Diphtheria, tetanus, and pertussis, recommendations for vaccine use and other preventive measures. MMWR 1991,40(RR-10):1-28
41. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection - epidemiologic, clinical and immunologic perspectives Ann Intern Med 1992;117:314-24.
42. Musher DM. Streptococcus pneumoniae. In Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone, 1995:1811-26.
43. Simberkoff MS, ElSadr W, Schiffman G, Rahal JJ Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984,130: 1174-6.
44. Ballet JJ, Sulcebe G, Couderc LJ, et al. Impaired antipneumococcal antibody response in patients with AIDS-related generalized lymphadenopathy. Clin Exp Immunol 1987;68: 479-87.
45. Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991;164:761-4.
46. Weiss PJ, Wallace MR, Oldfield EC, O'Brien J, Janoff EN. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine J Infect Dis 1995;171:1217-22.
47. Anonymous. Increase in pneumonia mortality among young adults and the HIV epidemic - New York City, United States. MMWR 1988;37:593-6.
48. Betts RF. Influenza virus. In. Mandell GL, Douglas RG, Bennett JE, eds Principles and practice of infectious diseases, 4th ed New York: Churchill Livingstone, 1995:1546-67
49. Douglas RG. Prophylaxis and treatment of influenza N Engl J Med 1990,322(7).443-50.
50. Ragni MV, Ruben FL, Winkelstein A, Spero JA, Bontempo FA, Lewis JH. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med 1987,109:545-9
51. Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989,262:779-83.
52. Murphy KR, Strunk RC. Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. J Pediatr 1985;106:931-3.
53. Immunization Practices Advisory Committee. Prevention and control of influenza. Part II. Antiviral agents MMWR 1994,43(RR-15):1-10.
54. Scharschmidt BF, Held MJ, Hollander HH, et al. Hepatitis B in patients with HIV infection, relationship to AIDS and patient survival. Arm Intern Med 1992,117 837-8.
55. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991,163.454-9.
56. Keet IPM, van Doornum G, Safary A, Coutinho RA. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men AIDS 1992;6 509-10
57. Loke RHT, Murray-Lyon IM, Coleman JC, Evans BA, Zuckerman AJ, Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody, an indicator of poor prognosis J Med Virol 1990;31:109-11
58. McEvoy GK. AHFS 95 drug information. Bethesda, MD. American Society of Hospital Pharmacists, 1995:2306-13
59. Steinhoff MC, Auerbach BS, Nelson KE, et al. Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection N Engl J Med 1991;325(26) 1837-42
60. Schreiber JR, Barrus V, Cates KL, Siber GR. Functional characterization of human IgG, IgM and IgA antibodies directed to the capsule of Haemophilus influence type b. J Infect Dis 1986;153(1):8-16